Glimelius, Bengt, et al. “Persistent Prevention of Oxaliplatin-Induced Peripheral Neuropathy Using Calmangafodipir (PledOx®): A Placebo-Controlled Randomised Phase II Study (PLIANT)”. Acta Oncologica, vol. 57, no. 3, Mar. 2018, pp. 393-02, doi:10.1080/0284186X.2017.1398836.